HY-133 is under clinical development by HyPharm and currently in Phase I for Staphylococcal Infections. According to GlobalData, Phase I drugs for Staphylococcal Infections have a 63% phase transition ...

P-128 is under clinical development by GangaGen Biotechnologies and currently in Phase II for Staphylococcus aureus Infections.

PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today announced the clinical results ...

Aux Terroirs is recalling certain Fromagerie des Grondines cheeses because of the possible presence of E. coli and Staphylococcus aureus. According to the ...

Nurse loses leg after cutting foot, contracting bacterial infection while on Florida vacation SURPRISE, Ariz. ( KPHO /Gray News) – A nurse in Arizona is adjusting to his new normal after losing his ...

A number of Fromagerie des Grondines cheeses sold by the brand Aux Terroirs are being recalled across Canada. The recall of ...

Tissue adhesive had a lower rate of surgical site infections when compared with suture for epidermal closure in dermatologic surgery.

A stye (medical term: hordeolum) is a common eye condition characterized by a small, painful lump or bump on the edge of the ...